Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Hypoglycemia

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

Hyperglycemia

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effects of the Omnipod 5 Hybrid Closed-Loop System in People With Type 1 Diabetes With Impaired Awareness of Hypoglycemia.

Diabetes care·2026

Same author

Hypoglycaemia Was Not Associated With Depression, Anxiety, Diabetes Distress or Fear of Hypoglycaemia Scores in People With Type 1 or Insulin-Treated Type 2 Diabetes in the Hypo-METRICS Study.

Diabetes, obesity & metabolism·2026

Same author

Corrigendum to "Relationship between severe hypoglycemia or impaired awareness of hypoglycemia and diabetes-related health status, global cognition and executive functions in adults with type 1 diabetes without severe anxiety or depression" [Diabetes Res Clin Pract 221 (2025) 112004. doi: 10.1016/j.diabres.2025.112004. Epub2025 Jan 11. PMID:39805380].

Diabetes research and clinical practice·2026

Same author

The Impact of Hypoglycaemia on Quality of Life in Adults With Type 1 Diabetes Using Contemporary Diabetes Technologies: A US National Survey.

Diabetes, obesity & metabolism·2026

Same author

Gender differences in hypoglycaemia in type 1 and insulin-treated type 2 diabetes: the Hypo-METRICS study.

Diabetologia·2026

Same author

Glucose-Derived Personalized HbA1c Correction (GDAC) Study to Improve Alignment Between CGM-Derived Metrics and HbA1c in Different Individuals and Racial Groups With Diabetes: Implications for Clinical Practice.

Diabetes care·2026

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Hypoglycaemia: current management and controversies.

Pratik Choudhary¹, Stephanie A Amiel

¹King's College London School of Medicine, 3.39, Weston Education Centre, Cutcombe Road, Denmark Hill Campus, Weston Education Centre, London SE5 9RJ, UK. pratik.choudhary@kcl.ac.uk

Postgraduate Medical Journal

|February 8, 2011

Summary

Hypoglycaemia, or low blood sugar, poses risks for diabetes patients, especially those on insulin. Managing this condition is key to preventing severe episodes and improving patient safety.

More Related Videos

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Related Experiment Videos

Last Updated: Jun 4, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Area of Science:

Endocrinology
Metabolic Diseases
Diabetes Management

Background:

Hypoglycaemia presents a significant burden, hindering tight glycemic control in diabetes patients.
Impaired awareness of hypoglycaemia due to repeated episodes increases the risk of severe events sixfold.
Incidence of hypoglycaemia is lower in type 2 diabetes but rises with insulin treatment duration, comorbidities, and age.

Purpose of the Study:

To review the challenges and management strategies for hypoglycaemia in diabetes.
To highlight the importance of awareness in preventing severe hypoglycaemic events.
To discuss the impact of modern diabetes treatments and patient-specific factors on hypoglycaemia risk.

Main Methods:

Literature review of studies on hypoglycaemia in diabetes.
Analysis of risk factors including insulin therapy, age, comorbidities, and lifestyle.
Evaluation of current and emerging therapeutic strategies for hypoglycaemia reduction.

Main Results:

Newer incretin-based therapies show low rates of hypoglycaemia.
Intensified glucose control can increase hypoglycaemia risk, potentially linked to mortality.
Driving restrictions for insulin-treated patients exist, but accident data is inconclusive.
Healthcare professionals often underemphasize driving guidelines for diabetic patients.

Conclusions:

Regular assessment of hypoglycaemia frequency, severity, and awareness is crucial for patients on hypoglycaemic agents.
Key strategies include patient education, modern insulin analogues, insulin pumps, and continuous glucose monitoring.
Islet or pancreas transplantation is an option for recurrent, disabling hypoglycaemia.